FDA Inspection 1027124 — Andrzej Galaj, MD
The FDA completed an inspection of Andrzej Galaj, MD on August 25, 2017 in Bydgoszcz. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 25, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Bydgoszcz (Poland)
Additional Details
Clinical Investigator (CI)